AXL Series: MOUD, Depression, and Suicidality



Date & Location
Wednesday, June 28, 2023, 12:00 PM - Sunday, June 28, 2026, 1:30 PM

Credits
AMA PRA Category 1 Credits™ (1.50 hours), ANCC Nursing Contact Hours (1.50 hours), CME-Designated Participation Credit (1.50 hours)

Overview

Learning Objectives

  • Define the prevalence and importance of co-occurring depression, suicidal behavior and opioid use disorder (OUD)
  • Define the assessment and management of depression and suicidality in patients with OUD
  • Discuss team-based approach to people at chronic and imminent risk of suicide
  • Discuss effective protocols/interventions to mitigate risk of suicide in patients with OUD

Presenter
Peter Jongho Na, MD, MPH   
Assistant Professor of Psychiatry: Yale School of Medicine

Learning Outcome
At the conclusion of this learning activity, (at least 75% of) participants will be able to assess level of risk for suicide in patients receiving MOUD. 

Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.

Lisa Marsch, PhD ~ has stock ownership and royalties/patients for Pear Therapeutics and stock ownership in Square2 Systems.

Peter Jongho Na, MD, MPH ~ receives royalties from Wolters Kluwer.

Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material

  • Bohnert A, Ilgen M. Understanding links among opioid use, overdose, and suicide. N Engl J Med, 380 (2019), pp. 71-79

  • Bohnert KM, Ilgen MA, Louzon S, McCarthy JF, Katz IR. Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction. 2017 Jul;112(7):1193-1201.

  • Gamarra JM, Luciano MT, Gradus JL, Stirman SW. Assessing variability and implementation fidelity of suicide prevention safety planning in a regional VA Healthcare System. Crisis. 2015;36(6):433-439. doi:10.1027/0227-5910/a000345.

  • Green, J. D., Kearns, J. C., Rosen, R. C., Keane, T. M., & Marx, B. P. Evaluating the effectiveness of safety plans in military veterans: Do safety plans tailored to veteran characteristics decrease risk?. Behavior Therapy. 2017. doi: 10.1016/j.beth.2017.11.005.

  • Na PJ, Bommersbach TJ, Petrakis IL, Rhee TG. National trends of suicidal ideation and mental health services use among US adults with opioid use disorder, 2009-2020. EClinicalMedicine. 2022 Oct 12;54:101696.

  • Na PJ, Scodes J, Fishman M, Rotrosen J, Nunes EV. Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone. J Clin Psychiatry. 2022 Apr 18;83(3):21m14140.

  • Office of Mental Health and Suicide Prevention. National Strategy for Preventing Veteran Suicide: 2018-2028. Washington, DC: U.S. Department of Veterans Affairs; 2018. Accessed September 24, 2018, at www.mentalhealth.va.gov/suicide_prevention/docs/Office-of-Mental-Health-and-Suicide-Prevention-National-Strategy-for-Preventing-Veterans-Suicide.pdf.

  • Oquendo M, Volkow N. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med, 378 (2018), pp. 1567-1569

  • Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale, Screening Version. Accessed September 24, 2018, at www.cssrs.columbia.edu.

  • Posner K, Brown GK, Stanley B, et al. The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults. The American Journal of Psychiatry. 2011;168(12):1266-1277. doi:10.1176/appi.ajp.2011.10111704.

  • Stanley, B & Brown, GK. Safety Planning Intervention: A brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice. 2012; 19: 256-264.

  • Stanley, B., Brown, G. K. with MacRae, F., Rotolo, C. A., Hughes, G., Mina, L. & Barry, C. N. (2018). Safety Planning Intervention Manual: Veteran Version. Washington, D.C.: United States Department of Veterans Affairs.

  • Stanley, B., Brown, G. K., Brenner, L. A., Galfalby, H. C., Currier, G. W., Knox, K. L., Chaudhury, S. R., Bush, A. L., & Green, K. L. (2018). Comparison of the Safety Planning Intervention With Follow-up vs Usual Care of Suicidal Patients Treated in the Emergency Department. JAMA Psychiatry. 2018; 75(9):894-900. doi: 10.1001/jamapsychiatry.2018.1776

  • VA/DoD clinical practice guideline for assessment and management of patients at risk for suicide. Washington, DC: U.S. Department of Veterans Affairs and Department of Defense. Accessed on September 24, 2018, at www.healthquality.va.gov/guidelines/MH/srb/VADODCP_suiciderisk_full.pdf

Accreditation

Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Dartmouth Health designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dartmouth Health Nursing Continuing Education Council is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity carries 1.50 contact hour(s).

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
  2. Register for the activity.
  3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
  4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).
  5. Click My Account in the menu bar; then click Evaluations.
  6. Complete and Submit the Evaluation.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CME/CNE Office
Dartmouth Health
[email protected]